February 2026 in “Psycho-Oncologie” This narrative review highlights that alopecia areata significantly impacts the psychological wellbeing of cancer patients, contributing to distress, anxiety, and depression, and underscores the importance of integrating dermatologic care with psycho-oncology to improve patient outcomes.
December 2025 in “PubMed” This study reports that baricitinib was effective and well-tolerated over 52 weeks for severe alopecia areata, with significant improvements in disease severity and no serious adverse events.
November 2025 in “Cureus” This study found that COVID-19 vaccines were generally well-tolerated among Bangladeshi medical students, with most side effects being mild and decreasing in frequency after subsequent doses.
August 2025 in “Skin Appendage Disorders” This review highlights that while low-dose oral minoxidil appears well-tolerated in cancer patients post-chemotherapy, its use during active chemotherapy has shown potential benefits but remains under investigation, with preclinical studies suggesting a protective effect against chemotherapy-induced alopecia.
July 2025 in “International Journal of Homoeopathic Sciences” This case study reported significant hair regrowth and overall improvement in well-being for a male with Alopecia Universalis after receiving classical homeopathic treatment at Dr. Batra’s, suggesting potential long-term benefits from this intervention.
June 2025 in “The Journal of Dermatology” This study found that baricitinib was effective and well tolerated for long-term scalp hair regrowth in severe alopecia areata patients, with certain predictors identified for treatment response.
April 2025 in “Tạp chí Y Dược học Cần Thơ” This review indicates that hair loss negatively impacts psychological well-being and quality of life, highlighting the importance of comprehensive management, including psychological assessment and sleep improvement, to enhance patients’ quality of life.
March 2025 in “International Journal of Trichology” This study reports that low-dose oral minoxidil is generally well tolerated from a cardiovascular perspective, and serious side effects like pericardial effusion are associated with higher doses and pre-existing conditions.
January 2025 in “The World Journal of Men s Health” In this study, autologous intratesticular PRP injection was found to be a feasible and well-tolerated procedure with low complication rates and quick recovery, but the authors indicated that current evidence is insufficient to confirm its effectiveness for mTESE.
November 2024 in “International Journal of Dermatology” This study found that line-field confocal optical coherence tomography correlates well with histopathological and dermoscopic findings in alopecia areata, suggesting it could be a useful diagnostic and monitoring tool for the condition.
This study highlights that most men experiencing hair loss respond well to medical or surgical treatments, and suggests combining hair transplant procedures with medical therapy to prevent further loss and enhance outcomes.
July 2023 in “Aesthetic Plastic Surgery” Both types of Platelet-Rich Plasma treatments work well for hair loss.
July 2023 in “Aesthetic Plastic Surgery” Both types of Platelet-Rich Plasma (PRP) treatments work well for hair loss.
March 2023 in “Journal of the American Academy of Dermatology” This review summarizes evidence that pityrosporum folliculitis in immunocompromised patients responds well to topical antifungals and treatment of underlying conditions, based on a limited number of studies with small sample sizes.
The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.
This study found that while iron supplements are generally well tolerated by patients with anemia, their clinical benefit in those without iron deficiency is modest.
January 2019 in “대한피부과학회지” This study found that patients with kerion responded well to antifungal treatments, with a lower dose of prednisolone effectively reducing inflammation when systemic corticosteroids were needed.
October 2018 in “Annals of oncology” This study reported that topical BPM31543 was safe and well-tolerated for patients on taxane-based chemotherapy, with some efficacy indicated in reducing hair loss at all dosages tested.
August 2018 in “Journal of The American Academy of Dermatology” The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.
December 2010 in “Dermatologic Surgery” Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.
July 2004 in “Clinics in Dermatology” This research introduced and validated the Scales of General Well-Being, which reliably measures overall and specific aspects of well-being across different demographics in North America.
September 1998 in “Journal of the European Academy of Dermatology and Venereology” This study found that PUVA-turban therapy was a well-tolerated and potentially effective treatment for certain patients with severe, treatment-resistant alopecia areata, inducing hair regrowth in some cases.
June 1996 in “Journal of Dermatological Science” Two new compounds were found that could promote hair growth as well or better than minoxidil.
April 1974 in “Pediatric Research” Monitoring nutrition and health is crucial for the well-being of institutionalized mentally retarded children.
November 1971 in “Bulletin of Experimental Biology and Medicine” The location of a skin injury affects how well a rat's skin can heal.
January 2023 in “Skin Research and Technology” This study created new methods to test how well hair care products clean and protect hair from pollution, finding a wide range of effectiveness among different formulas in removing pollutants and preventing their deposit on hair fibers.
December 2021 in “BMJ Open” This study found no significant association between androgenetic alopecia and psychosocial well-being among middle-aged men in the Northern Finland Birth Cohort.
November 2009 in “Cambridge University Press eBooks” This review discusses the necessity for hair transplant surgeons to be well-versed in both surgical and medical treatments for various forms of alopecia, and it reports no new results.
160 citations
,
January 2009 in “Clinical Drug Investigation” This study found that the HairMax LaserComb® significantly increased hair density and was safe and well tolerated for treating androgenetic alopecia in men compared to a sham device.
53 citations
,
September 2011 Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.